RIPK3 and hepatocellular carcinoma: This is exemplified by tumor-associated macrophages (TAM) for hepatocellular carcinoma (HCC), in which RIPK3 is down-regulated and attenuates ROS and caspase1-mediated PPAR cleavage, which enhanced PPAR-dependent FAO.111